129 related articles for article (PubMed ID: 12729799)
1. Multiprotein bridging factor 1 cooperates with c-Jun and is necessary for cardiac hypertrophy in vitro.
Busk PK; Wulf-Andersen L; Strøm CC; Enevoldsen M; Thirstrup K; Haunsø S; Sheikh SP
Exp Cell Res; 2003 May; 286(1):102-14. PubMed ID: 12729799
[TBL] [Abstract][Full Text] [Related]
2. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
Nadruz W; Kobarg CB; Constancio SS; Corat PD; Franchini KG
Circ Res; 2003 Feb; 92(2):243-51. PubMed ID: 12574153
[TBL] [Abstract][Full Text] [Related]
3. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
4. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
5. Focal adhesion kinase mediates MEF2 and c-Jun activation by stretch: role in the activation of the cardiac hypertrophic genetic program.
Nadruz W; Corat MA; Marin TM; Guimarães Pereira GA; Franchini KG
Cardiovasc Res; 2005 Oct; 68(1):87-97. PubMed ID: 15961069
[TBL] [Abstract][Full Text] [Related]
6. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
[TBL] [Abstract][Full Text] [Related]
8. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
9. Coactivator MBF1 preserves the redox-dependent AP-1 activity during oxidative stress in Drosophila.
Jindra M; Gaziova I; Uhlirova M; Okabe M; Hiromi Y; Hirose S
EMBO J; 2004 Sep; 23(17):3538-47. PubMed ID: 15306851
[TBL] [Abstract][Full Text] [Related]
10. A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
Lu Y; Wu F
Gene; 2018 Mar; 648():21-30. PubMed ID: 29339068
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.
Xie YY; Sun MM; Lou XF; Zhang C; Han F; Zhang BY; Wang P; Lu YM
J Pharmacol Sci; 2014; 125(3):274-82. PubMed ID: 25048017
[TBL] [Abstract][Full Text] [Related]
12. Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine.
Omura T; Yoshiyama M; Yoshida K; Nakamura Y; Kim S; Iwao H; Takeuchi K; Yoshikawa J
Hypertension; 2002 Jan; 39(1):81-6. PubMed ID: 11799083
[TBL] [Abstract][Full Text] [Related]
13. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
14. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
[TBL] [Abstract][Full Text] [Related]
15. Ca²⁺ signal-induced cardiomyocyte hypertrophy through activation of myocardin.
Li M; Wang N; Gong HQ; Li WZ; Liao XH; Yang XL; He HP; Cao DS; Zhang TC
Gene; 2015 Feb; 557(1):43-51. PubMed ID: 25485719
[TBL] [Abstract][Full Text] [Related]
16. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
[TBL] [Abstract][Full Text] [Related]
17. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
Pu WT; Ma Q; Izumo S
Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489
[TBL] [Abstract][Full Text] [Related]
18. Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate.
Zhou D; Liang Q; He X; Zhan C
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):531-4. PubMed ID: 18846332
[TBL] [Abstract][Full Text] [Related]
19. Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways.
Pan ZW; Zhang Y; Mei DH; Zhang R; Wang JH; Zhang XY; Xu CQ; Lu YJ; Yang BF
Naunyn Schmiedebergs Arch Pharmacol; 2010 Feb; 381(2):137-45. PubMed ID: 20052460
[TBL] [Abstract][Full Text] [Related]
20. The role of human MBF1 as a transcriptional coactivator.
Kabe Y; Goto M; Shima D; Imai T; Wada T; Morohashi Ki; Shirakawa M; Hirose S; Handa H
J Biol Chem; 1999 Nov; 274(48):34196-202. PubMed ID: 10567391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
